Skip to content

The effect of Mentha longifolia spray on patients with COVID-19

Explanation of Havay-e-Vabaie based on Iranian medicine and relation of it with epidemies. Determining the effect of the Iranian Medicine Product based on Mentha longifolia (nasal spray) on clinical and para clinical conditions of patients with COVID-19: clinical trial

Status
Active, not recruiting
Phases
Phase 2
Study type
Interventional
Source
IRCT
Registry ID
IRCT20200809048337N1
Enrollment
60
Registered
2022-11-29
Start date
2020-07-10
Completion date
Unknown
Last updated
2023-02-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

COVID-19. Diseases of the respiratory system

Interventions

Intervention 1: Intervention group: included patients who have been admitted to the corona sections o

Sponsors

Mazandaran University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 75 Years

Inclusion criteria

Inclusion criteria: Patients who, have one / more of the following symptoms, in addition to acute respiratory illness (ARI):•RR> 30•PO2 <93% •Pulmonary infiltration in chest x-ray •Clinical judgment of a specialist physician 2- Age range of (18-75) years of both sexes 3- patient must not have any serious simultaneous heart, lung, brain and endocrine diseases 4- The patient's ability and personal desire to fill out a personal consent form to enter the study

Exclusion criteria

Exclusion criteria: Pregnancy and breastfeeding Existence of any history of allergy to Mentha longifolia and its products patient's Inability to consume the oral form existence of any condition that prevents the continuing of the therapeutic intervention based on the physician's judgment Patient intubation Nausea and vomiting Resistant hypoxemia loss of consciousness Hemodynamic instability

Design outcomes

Primary

MeasureTime frame
Reduction of hospitalization rate. Timepoint: Daily. Method of measurement: Patient record.;Respiratory rate. Timepoint: Daily. Method of measurement: By RR monitor or manual counting of breaths.;Oxygen saturation. Timepoint: 8 am and 8 pm. Method of measurement: Pulsoximeter.

Secondary

MeasureTime frame
Heart rate. Timepoint: twice a day. Method of measurement: By monitor or manually.;Blood pressure measurement. Timepoint: Daily. Method of measurement: Mercury sphygmomanometer.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactYousofpour Mohammad

Mazandaran University of Medical Sciences

m.yousefpour@mazums.ac.ir+98 11 3304 4426

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026